1.Annexin A2 and pathogenesis of cancer: an update.
Chinese Journal of Pathology 2007;36(2):129-132
2.Laryngeal pleomorphic rhabdomyosarcoma: report of a case.
Chinese Journal of Pathology 2007;36(8):573-574
Adult
;
Diagnosis, Differential
;
Histiocytoma, Malignant Fibrous
;
pathology
;
Humans
;
Laryngeal Neoplasms
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Laryngectomy
;
Leiomyosarcoma
;
pathology
;
Male
;
Rhabdomyosarcoma
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Tomography, X-Ray Computed
;
Vimentin
;
metabolism
3.Advances in poorly differentiated thyroid carcinoma.
Jian SUN ; Di YANG ; Quan-cai CUI
Chinese Journal of Pathology 2011;40(12):850-853
Adenocarcinoma, Follicular
;
epidemiology
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
pathology
;
DNA-Binding Proteins
;
metabolism
;
Diagnosis, Differential
;
Genes, ras
;
genetics
;
Humans
;
Point Mutation
;
Prognosis
;
Thyroglobulin
;
metabolism
;
Thyroid Neoplasms
;
epidemiology
;
genetics
;
metabolism
;
pathology
;
Transcription Factors
4.Proteomics and its applications in the research of papillary thyroid carcinoma.
Jie SHI ; Zhao-hui LU ; Quan-cai CUI
Chinese Journal of Pathology 2007;36(10):691-693
Biomarkers, Tumor
;
metabolism
;
Carcinoma, Papillary
;
metabolism
;
Cathepsin B
;
metabolism
;
Cell Cycle Proteins
;
metabolism
;
HSP27 Heat-Shock Proteins
;
metabolism
;
Humans
;
Proteomics
;
Repressor Proteins
;
metabolism
;
S100 Calcium Binding Protein A6
;
S100 Proteins
;
metabolism
;
Serpins
;
metabolism
;
Thyroid Neoplasms
;
metabolism
6.The advances of molecular pathology of follicular thyroid carcinoma.
Chinese Journal of Pathology 2004;33(3):268-270
Adenocarcinoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Biomarkers, Tumor
;
genetics
;
Diagnosis, Differential
;
Humans
;
Matrix Metalloproteinase 1
;
biosynthesis
;
genetics
;
Telomerase
;
biosynthesis
;
genetics
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
ras Proteins
;
biosynthesis
;
genetics
7.Estrogen induced rat model of uterine leiomyoma.
Hai-gang CHEN ; Zhu LAN ; Quan-cai CUI ; Jing-he LANG ; Bin LI
Acta Academiae Medicinae Sinicae 2011;33(4):408-411
OBJECTIVETo establish an appropriate animal model of uterine leiomyoma and to understand the pathogenesis of this disease.
METHODSMature female rats were intramuscularly injected with estradiol benzoate at 200 μg or 300 μg twice a week. After injection for 8 or 10 weeks, the rats were sacrificed. We measured the serum levels of estrogen (E(2)) and progesterone (P), evaluated ER and PR expression, and calculated the leiomyoma forming rate and mortality of the rats. Histological changes were compared between rat uterine leiomyoma and human uterine leiomyoma with HE staining. The optimal dose and duration of E(2) for induction of uterine leiomyoma in rat were determined.
RESULTSIn the rats treated with estradiol benzoate 200 μg for 8 weeks ìn the serum E(2) level increased significantly (P<0.01). Uterine nodules were visible in some of the tested rats. Based on the pathohistological Results , the uterine leiomyoma developed in the treated rats demonstrated similar features as in human uterine leiomyoma. The expressions of ER and PR were increased in the leiomyoma tissues.
CONCLUSIONThe rat model of uterine leiomyoma can be established by intramuscular injection of estradiol benzoate at 200 μg twice per week for 8 weeks, with similar features as those of human uterine leiomyoma. The high concentrations of ER and PR in uterine tissue might be related with the development of uterine leiomyoma in animal.
Animals ; Disease Models, Animal ; Estrogens ; administration & dosage ; adverse effects ; Female ; Leiomyoma ; chemically induced ; Rats ; Uterine Neoplasms ; chemically induced
8.Advances in primary thyroid lymphoma.
Yuan LI ; Ding-rong ZHONG ; Quan-cai CUI
Acta Academiae Medicinae Sinicae 2006;28(5):724-729
Primary thyroid lymphomas (PTLs) are closely correlated with the autoimmune reaction of thyroid. However, the molecular mechanisms of PTLs are still unclear. It is really necessary to improve the ability to differentiate between benign and malignant PTLs along with the introduction of some new molecular biology methods. The diagnosis and prognosis of PTLs depend on their histological features, pathological classification, and clinical stages. Customized therapy of PTLs becomes possible with the further advances in lymphoma's pathological classification, clinical stages, and international prognosis index standard.
Humans
;
Lymphoma
;
diagnosis
;
pathology
;
therapy
;
Thyroid Neoplasms
;
diagnosis
;
pathology
;
therapy
9.Recent advances in gene change of pancreatic cancer.
Acta Academiae Medicinae Sinicae 2004;26(1):79-82
A large number of data derived from molecular analyses support the hypothesis that human cancer is a genetic disease and a distinct subset of genes have been found to be genetically changed in most tumors. Molecular alterations in pancreatic cancer include: (1) oncogenes such as K-ras, c-myc, c-fos, and c-erbB-2; (2) tumor suppressor genes such as p53, p16, DPC4/SMAD4, and DCC; and (3) growth factors such as EGF, FGF, HGF, PDGF, VEGF, TGF-beta. Genetic alterations of K-ras and p53 are common in human pancreatic cancer, but the occurrence of pancreatic cancer is a multi-step phenomenon in which the accumulation of genetic changes is extremely important.
Epidermal Growth Factor
;
genetics
;
Fibroblast Growth Factors
;
genetics
;
Genes, Tumor Suppressor
;
Genes, myc
;
genetics
;
Genes, p16
;
Genes, p53
;
genetics
;
Genes, ras
;
genetics
;
Growth Substances
;
genetics
;
metabolism
;
Humans
;
Oncogenes
;
genetics
;
Pancreatic Neoplasms
;
genetics
10.Gene rearrangement studies in Hashimoto's thyroiditis and primary lymphoma of thyroid.
Zhen HUO ; Yuan LI ; Ding-rong ZHONG ; Quan-cai CUI
Chinese Journal of Pathology 2006;35(6):344-347
OBJECTIVETo study the immunoglobulin gene rearrangement patterns in Hashimoto's thyroiditis (HT) and primary thyroid lymphoma (PTL), and to analyze the relationship between the two diseases.
METHODSFormalin-fixed and paraffin-embedded tissues of 11 cases of PTL and 38 cases of HT as well as their clinical data, were retrieved. The latter group was further subcategorized into classic HT and suspicious PTL. Gene rearrangement studies for immunoglobulin heavy chains and light chains were carried out by polymerase chain reaction (PCR) using VH, FR3A and FR3kappa primers.
RESULTSThere was an increasing trend in immunoglobulin gene rearrangement rate for classic HT (10.7%), suspicious PTL (40.0%) and PTL (72.7%) groups. In general, a female predilection was observed. This sex predilection however was less obvious in the PTL group. There was no relationship between serum antibody (both thyroglobulin and thyroid peroxidase) titers and gene rearrangement patterns.
CONCLUSIONSHT and PTL show morphologic overlaps and may not be clearly distinguished on the basis of light microscopy alone. PCR-based immunoglobulin gene rearrangement study may be helpful in the detection of cases with early lymphomatous transformation of HT.
Female ; Gender Identity ; Gene Rearrangement ; Hashimoto Disease ; genetics ; Humans ; Lymphoma ; genetics ; pathology ; Male ; Middle Aged ; Sex Characteristics ; Thyroid Neoplasms ; genetics ; pathology ; Thyroiditis, Autoimmune ; genetics